Smartphone-attached Epinephrine Autoinjector

About SemPresto

SemPresto is addressing a critical gap in anaphylaxis management: patient non-adherence to carrying bulky, traditional epinephrine autoinjectors. The company has developed a compact autoinjector that attaches directly to a smartphone case, leveraging the near-constant proximity of a phone to ensure the medication is always accessible. This consumer-centric hardware solution targets the large and growing population with severe allergies, where delayed epinephrine administration is a leading cause of poor outcomes. By integrating emergency treatment into daily life, SemPresto aims to improve real-world adherence and save lives.

Therapeutic Areas